Metabolically Healthy Obesity? Another Piece of the Puzzle
To allow for easier identification of MHO, a subset of obese individuals at lower risk of CVD death and all-cause mortality, investigators used data from 2 large patient cohorts to craft a definition of MHO based on common risk factors.
Can Inspiratory Muscle Strength Training Improve Heart Health?
This study that examined whether this type of strength training would improve blood pressure, endothelial function, and arterial stiffness in older patients with elevated systolic BP.
Recurrent CV Event Risk Hiked by Long Work Hours
Findings from a prospective cohort study indicate that reducing work hours—from 55 or more a week to between 35 and 40—may be a preventive strategy for patients with a history of heart attack.
BP and Sodium Intake: New Investigation, New Concerns
A meta-analysis demonstrated a positive and substantially linear relationship between sodium exposure and blood pressure, even at sodium intake levels lower than current public health recommendations.
Statin Use in People with ASCVD Could Be (Much) Better
Cholesterol guidelines recommend at least a moderate-intensity statin in older adults with ASCVD. But that’s not happening consistently in clinical practice.
STEMI Patients Without Risk Factors: New Strategies Needed
Data from the Swedish MI registry showed an increased risk of all-cause mortality in this group of patients, suggesting a need to re-examine use of evidence-based pharmacotherapy.
ASCVD Risk Stratification Using Family History
Validated family history is a key risk factor for ASCVD and may be the largest contributor to risk. An accurate family history of ASCVD can help determine the need for measuring CAC--and ultimately the need for lipid-lowering therapy.
ASCVD Primary Prevention: CAC Scanning Helps with the Aspirin Decision
A recent study explores whether coronary artery calcium levels can help identify patients most likely to experience a net benefit from aspirin therapy for ASCVD.
Elevated NT-ProBNP Identifies Subjects at High CV Risk
These data provide evidence that increased levels of NT-proBNP in patients without cardiovascular disease are associated with increased risk for cardiovascular events.